The daily dose: October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And thi

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Maha-Karnataka language row: Family to withdraw POCSO case against conductor

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation